Study title for participants: A Study of ZL-6201 in People With Sarcoma and Solid Tumor Cancer

Full Title

An Open-label, Phase 1a/b, Multicenter Study of ZL-6201 to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy in Participants with Sarcoma and Selected Solid Tumors

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description

Contact

For more information or to see if you can join this study, please call Dr. Robert Maki’s office at 646-888-5059.